Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.
Baum
Larry
L
Lam
Christopher Wai Kei
CW
Cheung
Stanley Kwok-Kuen
SK
Kwok
Timothy
T
Lui
Victor
V
Tsoh
Joshua
J
Lam
Linda
L
Leung
Vivian
V
Hui
Elsie
E
Ng
Chelsia
C
Woo
Jean
J
Chiu
Helen Fung Kum
HF
Goggins
William B
WB
Zee
Benny Chung-Ying
BC
Cheng
King Fai
KF
Fong
Carmen Yuet Shim
CY
Wong
Adrian
A
Mok
Hazel
H
Chow
Moses Sing Sum
MS
Ho
Ping Chuen
PC
Ip
Siu Po
SP
Ho
Chung Shun
CS
Yu
Xiong Wen
XW
Lai
Caroline Yau Lin
CY
Chan
Ming-Houng
MH
Szeto
Samuel
S
Chan
Iris Hiu Shuen
IH
Mok
Vincent
V
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D044466:Asian People; D002214:Capsules; D030024:Curcuma; D003474:Curcumin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006723:Hong Kong; D006801:Humans; D008297:Male; D008517:Phytotherapy; D010865:Pilot Projects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000975:Antioxidants; D002214:Capsules; D003474:Curcumin